The burden of skin diseases in China: global burden of Disease Study 2019.
Dermatitis
Global burden of Disease
Non-melanoma cell cancer
Scabies
Skin and subcutaneous diseases
Years lived with disability
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
25 May 2024
25 May 2024
Historique:
received:
07
04
2024
accepted:
26
04
2024
revised:
07
04
2024
medline:
26
5
2024
pubmed:
26
5
2024
entrez:
25
5
2024
Statut:
epublish
Résumé
Skin diseases continue to affect human health and cause a significant disease burden on the healthcare system.We aimed to report the changing trends in the burden of skin disease in China from 1990 to 2019, Which has an important role in developing targeted prevention strategies. We applied Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2019 analytical tools to calculate the age-standardized Prevalence and Incidence in 2019, number of years lived with disability (YLDs) and age-standardized YLDs from 1990 to 2019 of skin and subcutaneous diseases, notifiable infectious skin diseases and skin tumors in China. Among the skin and subcutaneous diseases in China in 2019, dermatitis contributed to the greatest YLD (2.17 million, 95% uncertainty interval[UI]: 1.28-3.36). Age-standardized YLD rates for leprosy decreased from 0.09 (95%UI: 0.06-0.13) in 1990 to 0.04 (95%UI: 0.03-0.06) in 2019; the proportional decrease was 55.56% over 30 years. Age-standardized YLDs for HIV and sexually transmitted infections increased by 26% during the same time period. Age-standardized YLDs for non-melanoma skin cancer increased at a much higher rate than melanoma between 1990 and 2019. Dermatitis and scabies continue to have an important role in the burden of skin and subcutaneous disease burden in China. The burden of non-melanoma cell cancer has increased most significantly over the past three decades.
Identifiants
pubmed: 38796625
doi: 10.1007/s00403-024-03046-5
pii: 10.1007/s00403-024-03046-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
277Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
World Health Organization Epidemiology and management of common skin diseases in children in developing countries (Internet). https://iris.who.int/handle/10665/69229
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA, Wulf SK, Michaud C, Murray JL, Naghavi C M (2014) The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 134(6):1527–1534
doi: 10.1038/jid.2013.446
pubmed: 24166134
Wu JH, Cohen BA (2019) The stigma of skin disease. Curr Opin Pediatr 31(4):509–514
doi: 10.1097/MOP.0000000000000792
pubmed: 31188167
Laughter MR, Maymone MBC, Karimkhani C, Rundle C, Hu S, Wolfe S, Abuabara K, Hollingsworth P, Weintraub GS, Dunnick CA, Kisa A, Damiani G, Sheikh A, Singh JA, Fukumoto T, Desai R, Grada A, Filip I, Radfar A, Naghavi M, Dellavalle RP (2020) The Burden of skin and Subcutaneous diseases in the United States from 1990 to 2017. JAMA Dermatol 156(8):874–881
doi: 10.1001/jamadermatol.2020.1573
pubmed: 32520352
Kavita A, Thakur JS, Narang T (2023) The burden of skin diseases in India: global burden of Disease Study 2017. Indian J Dermatol Venereol Leprol 89(3):421–425
doi: 10.25259/IJDVL_978_20
pubmed: 34877854
Dong W, An J, Geng P, Zeng X, Chen Y, Zhao Z, Zhou M (2020) Years lost due to disability from skin diseases in China 1990–2017: findings from the global burden of Disease Study 2017. Br J Dermatol 182(1):248–250
pubmed: 31278743
Peng D, Sun J, Wang J, Qi X, Li G (2021) Burden of skin disease - China, 1990–2019. China CDC Wkly 3(22):472–475
doi: 10.46234/ccdcw2021.123
pubmed: 34594916
pmcid: 8393111
GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1204–1222
doi: 10.1016/S0140-6736(20)30925-9
Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S (2015) Disability weights for the global burden of Disease 2013 study. Lancet Glob Health 3(11):e712–e723
doi: 10.1016/S2214-109X(15)00069-8
pubmed: 26475018
Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM (2021) The global burden of atopic dermatitis: lessons from the global burden of Disease Study 1990–2017. Br J Dermatol 184(2):304–309
doi: 10.1111/bjd.19580
pubmed: 33006135
Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345–360
doi: 10.1016/S0140-6736(20)31286-1
pubmed: 32738956
Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI (2009) Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 124(6):1251–8e23
doi: 10.1016/j.jaci.2009.10.009
pubmed: 20004783
Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM (2018) The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 73(3):696–704
doi: 10.1111/all.13320
pubmed: 28960336
Sunderkötter C, Wohlrab J, Hamm H (2021) Scabies: epidemiology, diagnosis, and treatment. Dtsch Arztebl Int 118(41):695–704
pubmed: 34615594
pmcid: 8743988
Seidelman J, Garza RM, Smith CM, Fowler VG Jr (2017) More than a Mite Contagious: Crusted Scabies. Am J Med 130(9):1042–1044
doi: 10.1016/j.amjmed.2017.05.007
pubmed: 28601538
Cassell JA, Middleton J, Nalabanda A, Lanza S, Head MG, Bostock J, Hewitt K, Jones CI, Darley C, Karir S, Walker SL (2018) Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 18(8):894–902
doi: 10.1016/S1473-3099(18)30347-5
pubmed: 30068499
pmcid: 6060176
Zhang W, Zhang Y, Luo L, Huang W, Shen X, Dong X, Zeng W, Lu H (2020) Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017. Emerg Microbes Infect 9(1):813–816
doi: 10.1080/22221751.2020.1754136
pubmed: 32284022
pmcid: 7241492
World Health Organization Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives (Internet). https://www.who.int/publications/i/item/who-wer9536
Vieira MCA, Nery JS, Paixão ES, Freitas de Andrade KV, Oliveira Penna G, Teixeira MG (2018) Leprosy in children under 15 years of age in Brazil: a systematic review of the literature. PLoS Negl Trop Dis 12(10):e0006788
doi: 10.1371/journal.pntd.0006788
pubmed: 30278054
pmcid: 6168122
Dharmawan Y, Fuady A, Korfage I, Richardus JH (2021) Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis 15(8):e0009651
doi: 10.1371/journal.pntd.0009651
pubmed: 34383768
pmcid: 8360380
Peiwen S, Wang Le, Wang Hongsheng, Liangbin Yan, Meiwen Yu (2023) Epidemiological characteristics of leprosy in China from 2016 to 2020. Chin J Dermatol 56(3):204–209
Chu T, Liu D, Huai P, Chen X, Han S, Chen S, Zhang F (2020) Comprehensive measures succeeded in improving early detection of leprosy cases in post-elimination era: experience from Shandong province, China. PLoS Negl Trop Dis 14(2):e0007891
doi: 10.1371/journal.pntd.0007891
pubmed: 32078623
pmcid: 7062278
Zheng Y, Yu Q, Lin Y, Zhou Y, Lan L, Yang S, Wu J (2022) Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis 22(4):541–551
doi: 10.1016/S1473-3099(21)00448-5
pubmed: 34942091
Taylor MM, Frasure-Williams J, Burnett P, Park IU (2016) Interventions to improve sexually transmitted Disease Screening in Clinic-based settings. Sex Transm Dis 43(2 Suppl 1):S28–S41
doi: 10.1097/OLQ.0000000000000294
pubmed: 26779685
pmcid: 6751565
Rietmeijer CA Improving care for sexually transmitted infections (2019). J Int AIDS Soc 22 Suppl 6 (Suppl Suppl 6):e25349
World Health Organization Report on global sexually transmitted infection surveillance 2018 (Internet). https://www.who.int/reproductivehealth/publications/stissurveillance-2018/en/
World Health Organization Global health sector strategy on sexually transmitted infections 2016–2021 (Internet). https://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/
Leigh IM (2014) Progress in skin cancer: the U.K. experience. Br J Dermatol 171(3):443–445
doi: 10.1111/bjd.13258
pubmed: 25234058
Hu W, Fang L, Ni R, Zhang H, Pan G (2022) Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer 22(1):836
doi: 10.1186/s12885-022-09940-3
pubmed: 35907848
pmcid: 9339183
Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 29(3):160–169
doi: 10.1016/j.soncn.2013.06.002
pubmed: 23958214
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A (2017) The Burden of Primary Liver Cancer and underlying etiologies from 1990 to 2015 at the Global, Regional, and National Level: results from the global burden of Disease Study 2015. JAMA Oncol 3(12):1683–1691
doi: 10.1001/jamaoncol.2017.3055
pmcid: 5824275
Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, Bernabei R, Peris K (2017) Skin Cancer epidemics in the Elderly as an emerging issue in geriatric oncology. Aging Dis 8(5):643–661
doi: 10.14336/AD.2017.0503
pubmed: 28966807
pmcid: 5614327